NASDAQ : MESO
Mesoblast Limited — Financial statements
Healthcare · Biotechnology · Australia
Last price 15.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Mesoblast Limited (MESO) reported revenue of 120.25M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 120.25M | 120.25M | 17.20M | 5.90M | 7.50M | 10.21M |
| Cost of Revenue | 24.03M | 24.03M | 17.62M | 2.95M | 52.82M | 63.57M |
| Gross Profit | 96.22M | 96.22M | -419.00K | 2.95M | -45.31M | -53.36M |
| Selling, General & Admin | 57.35M | 57.35M | 39.31M | 24.98M | 27.48M | 27.21M |
| Research & Development | 90.15M | 90.15M | 22.32M | 36.77M | ||
| Other Operating Expenses | -22.00K | -22.00K | 395.00K | -732.00K | -3.51M | 3.00K |
| Operating Expenses | 147.47M | 147.47M | 62.02M | 61.01M | 23.97M | 27.21M |
| Operating Income | -51.25M | -51.25M | -62.44M | -58.06M | -69.29M | -80.57M |
| Interest Expense | -19.87M | -19.87M | -21.75M | -20.66M | -19.44M | -16.91M |
| Interest & Investment Income | 3.91M | 3.91M | 3.55M | 360.00K | 831.00K | 3.00K |
| Currency Exchange Gain (Loss) | 1.07M | 1.07M | -106.00K | 1.18M | -163.00K | -536.00K |
| Other Non Operating Income (Expenses) | -3.11M | -3.11M | -6.18M | -1.57M | -2.88M | 5.51M |
| EBT Excluding Unusual Items | -69.25M | -69.25M | -86.92M | -78.76M | -90.95M | -92.50M |
| Asset Writedown | -85.00K | -85.00K | -85.00K | 76.00K | ||
| Other Unusual Items | 12.45M | 12.45M | -14.89M | -9.30M | 8.77M | 913.00K |
| Pretax Income | -56.89M | -56.89M | -101.81M | -88.15M | -82.10M | -91.59M |
| Income Tax Expense | 613.00K | 613.00K | 330.00K | -191.00K | -212.00K | -239.00K |
| Net Income | -57.50M | -57.50M | -102.14M | -87.96M | -81.89M | -91.35M |
| Net Income to Common | -57.50M | -57.50M | -102.14M | -87.96M | -81.89M | -91.35M |
| Shares Outstanding (Basic) | 1.29B | 1.29B | 1.21B | 986.70M | 777.72M | 682.86M |
| Shares Outstanding (Diluted) | 1.29B | 1.29B | 1.21B | 986.70M | 777.72M | 682.86M |
| EPS (Basic) | -0.04 | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 |
| EPS (Diluted) | -0.04 | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 |
| Free Cash Flow | -44.66M | -44.66M | -50.63M | -48.73M | -63.53M | -65.94M |
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.05 | -0.08 | -0.10 |
| Gross Margin | 80.02% | 80.02% | -2.44% | 50.02% | ||
| Operating Margin | -42.62% | -42.62% | -363.08% | -983.77% | -923.73% | -789.09% |
| Profit Margin | -47.82% | -47.82% | -593.92% | -1,490.27% | -1,091.71% | -894.59% |
| Free Cash Flow Margin | -37.14% | -37.14% | -294.42% | -825.63% | -846.99% | -645.76% |
| EBITDA | -44.60M | -44.60M | -58.18M | -56.17M | -66.84M | -77.91M |
| EBITDA Margin | -37.09% | -37.09% | ||||
| D&A For EBITDA | 6.64M | 6.64M | 4.26M | 1.90M | 2.45M | 2.66M |
| EBIT | -51.25M | -51.25M | -62.44M | -58.06M | -69.29M | -80.57M |
| EBIT Margin | -42.62% | -42.62% | ||||
| Revenue as Reported | 120.25M | 120.25M | 17.20M | 5.90M | 7.50M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 102.91M | 102.91M | 161.55M | 62.96M | 71.32M | 60.45M |
| Cash & Short-Term Investments | 102.91M | 102.91M | 161.55M | 62.96M | 71.32M | 60.45M |
| Accounts Receivable | 57.08M | 57.08M | 13.91M | 1.63M | 2.47M | 2.22M |
| Other Receivables | 584.00K | 584.00K | 955.00K | 18.85M | 4.06M | 1.71M |
| Receivables | 57.66M | 57.66M | 14.87M | 20.48M | 6.53M | 3.93M |
| Inventory | 28.11M | 28.11M | 22.25M | |||
| Prepaid Expenses | 8.37M | 8.37M | 4.29M | 2.16M | 2.39M | 3.67M |
| Other Current Assets | 441.00K | 441.00K | 1.40M | 862.00K | 1.42M | 1.78M |
| Total Current Assets | 197.49M | 197.49M | 204.35M | 86.46M | 81.66M | 69.84M |
| Property, Plant & Equipment | 8.01M | 8.01M | 5.82M | 3.84M | 6.49M | 9.96M |
| Long-Term Investments | 1.39M | 1.01M | 1.76M | 1.76M | ||
| Goodwill | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M |
| Other Intangible Assets | 431.92M | 431.92M | 437.37M | 441.28M | 442.73M | 444.20M |
| Long-Term Accounts Receivable | 190.00K | 414.00K | ||||
| Other Long-Term Assets | 1.20M | 1.20M | 1.30M | 1.91M | 1.91M | 1.93M |
| Total Assets | 773.08M | 773.08M | 784.68M | 669.15M | 669.41M | 662.14M |
| Accounts Payable | 34.51M | 34.51M | 18.13M | 7.07M | 20.14M | 23.08M |
| Accrued Expenses | 20.31M | 20.31M | 7.18M | 7.44M | 2.01M | 3.33M |
| Current Portion of Long-Term Debt | 10.60M | 10.60M | 54.16M | 13.86M | 5.95M | 5.02M |
| Current Portion of Leases | 3.03M | 3.03M | 2.68M | 2.63M | 4.06M | 3.19M |
| Other Current Liabilities | 12.66M | 12.66M | 20.48M | 42.25M | 9.81M | 16.76M |
| Total Current Liabilities | 81.11M | 81.11M | 102.63M | 73.24M | 41.98M | 51.37M |
| Long-Term Debt | 108.64M | 108.64M | 67.74M | 100.48M | 102.81M | 91.62M |
| Long-Term Leases | 5.07M | 5.07M | 3.58M | 1.95M | 3.67M | 7.08M |
| Other Long-Term Liabilities | 9.86M | 9.86M | 13.29M | 13.12M | 19.11M | 15.02M |
| Total Liabilities | 204.67M | 204.67M | 187.24M | 188.80M | 167.58M | 165.10M |
| Common Stock | 1.53B | 1.53B | 1.51B | 1.31B | 1.25B | 1.17B |
| Retained Earnings | -1.07B | -1.07B | -1.01B | -908.76M | -820.80M | -738.92M |
| Comprehensive Income & Other | 106.03M | 106.03M | 99.50M | 78.30M | 73.52M | 70.65M |
| Shareholders' Equity | 568.40M | 568.40M | 597.44M | 480.36M | 501.84M | 497.04M |
| Total Liabilities & Equity | 773.08M | 773.08M | 784.68M | 669.15M | 669.41M | 662.14M |
| Total Debt | 127.33M | 127.33M | 128.16M | 118.92M | 116.50M | 106.91M |
| Net Cash (Debt) | -24.42M | -24.42M | 33.39M | -55.96M | -45.18M | -46.46M |
| Net Cash Per Share | -0.02 | -0.02 | 0.03 | -0.06 | -0.06 | -0.07 |
| Filing Date Shares Outstanding | 1.30B | 1.30B | 1.28B | 1.14B | 813.66M | 737.12M |
| Total Common Shares Outstanding | 1.30B | 1.30B | 1.28B | 1.14B | 813.66M | 649.91M |
| Working Capital | 116.38M | 116.38M | 101.72M | 13.22M | 39.68M | 18.46M |
| Book Value Per Share | 0.44 | 0.44 | 0.47 | 0.42 | 0.62 | 0.76 |
| Tangible Book Value | 2.04M | 2.04M | 25.62M | -95.38M | -75.34M | -81.61M |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.02 | -0.08 | -0.09 | -0.13 |
| Machinery | 10.27M | 10.27M | 9.65M | 8.76M | 12.34M | 12.15M |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -57.50M | -57.50M | -102.14M | -87.96M | -81.89M | -91.35M |
| Depreciation & Amortization | 8.59M | 8.59M | 6.40M | 4.67M | 4.11M | 4.38M |
| Stock-Based Compensation | 14.87M | 14.87M | 22.09M | 5.87M | 3.65M | 5.54M |
| Other Operating Activities | 14.03M | 14.03M | 26.74M | 31.59M | 13.33M | 10.78M |
| Change in Accounts Receivable | -42.83M | -42.83M | 5.02M | -15.47M | -118.00K | 140.00K |
| Change in Inventory | -6.02M | -6.02M | 826.00K | |||
| Change in Accounts Payable | 25.69M | 25.69M | 11.78M | -12.38M | -398.00K | 4.78M |
| Change in Other Net Operating Assets | -654.00K | -654.00K | -21.94M | 23.72M | 432.00K | -48.00K |
| Operating Cash Flow | -43.83M | -43.83M | -49.95M | -48.46M | -63.27M | -65.78M |
| Capital Expenditures | -833.00K | -833.00K | -680.00K | -271.00K | -264.00K | -157.00K |
| Sale (Purchase) of Intangibles | -65.00K | -65.00K | -50.00K | -60.00K | -50.00K | -75.00K |
| Other Investing Activities | 609.00K | |||||
| Investing Cash Flow | -1.02M | -1.02M | 120.00K | -97.00K | -194.00K | -232.00K |
| Long-Term Debt Issued | 121.35M | 121.35M | 51.92M | |||
| Long-Term Debt Repaid | -127.29M | -127.29M | -9.77M | -13.52M | -2.66M | -58.25M |
| Lease Payments | -2.31M | -2.31M | -1.94M | -3.52M | -2.66M | -2.79M |
| Net Debt Issued (Repaid) | -5.94M | -5.94M | -9.77M | -13.52M | -2.66M | -6.33M |
| Issuance of Common Stock | 10.28M | 10.28M | 166.38M | 65.41M | 88.64M | 209.00K |
| Other Financing Activities | -19.68M | -19.68M | -9.28M | -11.63M | -11.48M | -3.75M |
| Financing Cash Flow | -15.33M | -15.33M | 147.34M | 40.25M | 74.50M | -9.87M |
| Foreign Exchange Rate Adjustments | 1.54M | 1.54M | 1.09M | -55.00K | -168.00K | -550.00K |
| Net Cash Flow | -58.64M | -58.64M | 98.59M | -8.36M | 10.87M | -76.43M |
| Free Cash Flow | -44.66M | -44.66M | -50.63M | -48.73M | -63.53M | -65.94M |
| Free Cash Flow Margin | -37.14% | -37.14% | -294.42% | -825.63% | -846.99% | -645.76% |
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.05 | -0.08 | -0.10 |
| Levered Free Cash Flow | -51.98M | -51.98M | -55.12M | -27.37M | -60.16M | -44.27M |
| Unlevered Free Cash Flow | -39.56M | -39.56M | -41.53M | -14.46M | -48.01M | -33.70M |
| Free Cash Flow After Leases | -46.97M | -46.97M | -52.58M | -52.25M | -66.19M | -68.73M |
| Cash Interest Paid | 17.76M | 17.76M | 5.27M | 5.72M | 6.01M | 6.08M |
| Cash Income Tax Paid | -1.00K | -1.00K | 2.00K | -4.00K | -20.00K | 24.00K |
| Change in Working Capital | -23.82M | -23.82M | -3.04M | -2.63M | -2.47M | 4.87M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.97B | 1.75B | 1.39B | 753.82M | 614.65M | 273.15M |
| Enterprise Value | 1.99B | 1.76B | 1.48B | 797.32M | 679.96M | 298.76M |
| Last Close Price | 15.16 | 13.53 | 10.89 | 6.81 | 7.82 | 4.44 |
| PS Ratio | 16.41 | 14.57 | 80.58 | 127.72 | 81.94 | 26.75 |
| PB Ratio | 3.47 | 3.08 | 2.32 | 1.57 | 1.23 | 0.55 |
| P/TBV Ratio | 969.69 | 861.25 | 54.10 | |||
| EV/Sales Ratio | 16.62 | 14.62 | 86.01 | 135.09 | 90.65 | 29.26 |
| Debt / Equity Ratio | 0.22 | 0.22 | 0.21 | 0.25 | 0.23 | 0.21 |
| Net Debt / Equity Ratio | 0.04 | 0.04 | -0.06 | 0.12 | 0.09 | 0.09 |
| Net Debt / EBITDA Ratio | -0.55 | -0.55 | 0.57 | -1.00 | -0.68 | -0.60 |
| Net Debt / FCF Ratio | -0.55 | -0.55 | 0.66 | -1.15 | -0.71 | -0.70 |
| Asset Turnover | 0.15 | 0.15 | 0.02 | 0.01 | 0.01 | 0.01 |
| Inventory Turnover | 0.95 | 0.95 | ||||
| Quick Ratio | 1.98 | 1.98 | 1.72 | 1.14 | 1.85 | 1.25 |
| Current Ratio | 2.44 | 2.44 | 1.99 | 1.18 | 1.95 | 1.36 |
| Return on Equity (ROE) | -9.86% | -9.86% | -18.95% | -17.91% | -16.40% | -16.94% |
| Return on Assets (ROA) | -4.11% | -4.11% | -5.37% | -5.42% | -6.50% | -7.16% |
| Return on Capital Employed (ROCE) | -7.40% | -7.40% | -9.20% | -9.70% | -11.00% | -13.20% |
| Earnings Yield | -2.98% | -3.28% | -7.37% | -11.67% | -13.32% | -33.44% |
| FCF Yield | -2.26% | -2.55% | -3.65% | -6.46% | -10.34% | -24.14% |
| Buyback Yield / Dilution | -7.21% | -7.21% | -22.41% | -26.87% | -13.89% | -12.86% |